| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neurilemmoma | 34 | 2022 | 523 | 3.500 |
Why?
|
| Neurofibromatosis 1 | 18 | 2024 | 561 | 3.400 |
Why?
|
| Neurofibromatosis 2 | 31 | 2022 | 383 | 3.190 |
Why?
|
| Neurofibromatoses | 12 | 2022 | 299 | 1.730 |
Why?
|
| Neurofibromin 2 | 24 | 2021 | 269 | 1.590 |
Why?
|
| Meningioma | 31 | 2021 | 1216 | 1.560 |
Why?
|
| Neuroma, Acoustic | 11 | 2019 | 458 | 1.240 |
Why?
|
| Neurofibroma | 5 | 2023 | 95 | 1.170 |
Why?
|
| Meningeal Neoplasms | 21 | 2021 | 1246 | 1.050 |
Why?
|
| Nerve Sheath Neoplasms | 6 | 2020 | 170 | 1.030 |
Why?
|
| Hamartoma | 4 | 2024 | 236 | 0.900 |
Why?
|
| Myositis | 3 | 2024 | 270 | 0.840 |
Why?
|
| Skin Neoplasms | 13 | 2023 | 5809 | 0.770 |
Why?
|
| Genes, Neurofibromatosis 2 | 10 | 2011 | 122 | 0.770 |
Why?
|
| Peripheral Nervous System Neoplasms | 6 | 2017 | 133 | 0.760 |
Why?
|
| Brain Neoplasms | 29 | 2024 | 9025 | 0.660 |
Why?
|
| Carbon Monoxide Poisoning | 1 | 2019 | 65 | 0.610 |
Why?
|
| Glioblastoma | 15 | 2021 | 3482 | 0.570 |
Why?
|
| Tuberous Sclerosis | 12 | 2018 | 1031 | 0.540 |
Why?
|
| Glioma | 13 | 2024 | 3452 | 0.530 |
Why?
|
| Hearing Loss | 5 | 2021 | 782 | 0.500 |
Why?
|
| Mucormycosis | 1 | 2016 | 102 | 0.480 |
Why?
|
| Schwann Cells | 11 | 2019 | 196 | 0.460 |
Why?
|
| Meningoencephalitis | 1 | 2014 | 83 | 0.450 |
Why?
|
| Immunohistochemistry | 31 | 2022 | 11067 | 0.440 |
Why?
|
| Oncolytic Virotherapy | 9 | 2020 | 515 | 0.430 |
Why?
|
| Eye | 1 | 2017 | 713 | 0.420 |
Why?
|
| Cranial Nerve Neoplasms | 2 | 2008 | 134 | 0.410 |
Why?
|
| Simplexvirus | 6 | 2016 | 801 | 0.410 |
Why?
|
| Ear Neoplasms | 1 | 2013 | 118 | 0.410 |
Why?
|
| Dependovirus | 5 | 2021 | 712 | 0.390 |
Why?
|
| Ependymoma | 3 | 2012 | 320 | 0.390 |
Why?
|
| Choroid | 2 | 2024 | 363 | 0.380 |
Why?
|
| Susac Syndrome | 1 | 2011 | 22 | 0.380 |
Why?
|
| Frontal Lobe | 2 | 2015 | 1416 | 0.380 |
Why?
|
| Neoplasms, Connective Tissue | 1 | 2010 | 36 | 0.360 |
Why?
|
| Encephalitis | 1 | 2014 | 438 | 0.360 |
Why?
|
| Microfilament Proteins | 6 | 2013 | 1130 | 0.360 |
Why?
|
| Occupational Diseases | 1 | 2019 | 1490 | 0.350 |
Why?
|
| Phosphoproteins | 7 | 2018 | 2444 | 0.350 |
Why?
|
| Diagnosis, Differential | 17 | 2018 | 12976 | 0.350 |
Why?
|
| Isocitrate Dehydrogenase | 4 | 2024 | 937 | 0.340 |
Why?
|
| Neurofibromin 1 | 5 | 2016 | 190 | 0.340 |
Why?
|
| Gene Expression Regulation, Neoplastic | 16 | 2019 | 8531 | 0.340 |
Why?
|
| Tumor Suppressor Proteins | 14 | 2015 | 2803 | 0.340 |
Why?
|
| Membrane Proteins | 11 | 2020 | 7851 | 0.340 |
Why?
|
| Sciatic Nerve | 7 | 2022 | 618 | 0.330 |
Why?
|
| Hydrocephalus | 1 | 2016 | 764 | 0.320 |
Why?
|
| Pituitary Gland, Posterior | 1 | 2008 | 42 | 0.320 |
Why?
|
| Ear, Inner | 1 | 2013 | 425 | 0.320 |
Why?
|
| Chromosomal Proteins, Non-Histone | 4 | 2015 | 725 | 0.320 |
Why?
|
| Autopsy | 4 | 2024 | 1010 | 0.320 |
Why?
|
| Brain | 13 | 2018 | 27094 | 0.310 |
Why?
|
| Brain Diseases | 2 | 2016 | 1545 | 0.310 |
Why?
|
| Sella Turcica | 1 | 2008 | 117 | 0.300 |
Why?
|
| Oligodendroglioma | 3 | 2005 | 278 | 0.290 |
Why?
|
| Neoplasm Proteins | 8 | 2017 | 3594 | 0.290 |
Why?
|
| Genes, Neoplasm | 1 | 2009 | 370 | 0.290 |
Why?
|
| Humans | 157 | 2024 | 761222 | 0.280 |
Why?
|
| Vestibulocochlear Nerve | 2 | 2019 | 115 | 0.280 |
Why?
|
| Gait Ataxia | 1 | 2006 | 11 | 0.280 |
Why?
|
| Mice | 57 | 2023 | 81330 | 0.270 |
Why?
|
| Oncolytic Viruses | 3 | 2020 | 344 | 0.260 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 6 | 2018 | 697 | 0.260 |
Why?
|
| Pituitary Neoplasms | 3 | 2008 | 1322 | 0.250 |
Why?
|
| Meningitis, Bacterial | 1 | 2007 | 222 | 0.250 |
Why?
|
| Alcoholism | 1 | 2016 | 1973 | 0.240 |
Why?
|
| Central Nervous System Neoplasms | 4 | 2017 | 915 | 0.240 |
Why?
|
| Spinal Nerves | 1 | 2005 | 90 | 0.240 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 3 | 2017 | 305 | 0.240 |
Why?
|
| Hearing | 4 | 2019 | 502 | 0.240 |
Why?
|
| Tumor Cells, Cultured | 14 | 2019 | 6125 | 0.230 |
Why?
|
| Vascular Endothelial Growth Factor A | 6 | 2017 | 3493 | 0.230 |
Why?
|
| Cell Proliferation | 18 | 2019 | 10423 | 0.230 |
Why?
|
| Interferon-beta | 2 | 2018 | 345 | 0.220 |
Why?
|
| Disease Models, Animal | 21 | 2020 | 18222 | 0.220 |
Why?
|
| Oligodendroglia | 3 | 2018 | 537 | 0.220 |
Why?
|
| Mice, Nude | 13 | 2021 | 3606 | 0.220 |
Why?
|
| Neurofibroma, Plexiform | 2 | 2018 | 66 | 0.220 |
Why?
|
| Animals | 66 | 2023 | 168089 | 0.220 |
Why?
|
| Caspase 1 | 3 | 2019 | 226 | 0.210 |
Why?
|
| Temporal Bone | 1 | 2007 | 683 | 0.210 |
Why?
|
| Cell Line, Tumor | 22 | 2021 | 16954 | 0.210 |
Why?
|
| Cytoskeletal Proteins | 3 | 2008 | 1334 | 0.210 |
Why?
|
| Angiogenesis Inhibitors | 5 | 2013 | 2047 | 0.200 |
Why?
|
| DNA-Binding Proteins | 6 | 2016 | 9567 | 0.200 |
Why?
|
| Angiomatosis | 2 | 2005 | 46 | 0.200 |
Why?
|
| Genetic Vectors | 8 | 2021 | 3388 | 0.200 |
Why?
|
| Transcription Factors | 10 | 2020 | 12101 | 0.200 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 4 | 2004 | 326 | 0.190 |
Why?
|
| Fatal Outcome | 3 | 2016 | 1838 | 0.190 |
Why?
|
| Optic Nerve Neoplasms | 2 | 2015 | 45 | 0.190 |
Why?
|
| Oculomotor Muscles | 2 | 2024 | 405 | 0.190 |
Why?
|
| Xenograft Model Antitumor Assays | 10 | 2021 | 3593 | 0.190 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2018 | 2897 | 0.190 |
Why?
|
| Fibroblast Growth Factor 7 | 1 | 2021 | 59 | 0.190 |
Why?
|
| Spinal Cord Neoplasms | 2 | 2014 | 261 | 0.190 |
Why?
|
| Dysarthria | 2 | 2014 | 57 | 0.180 |
Why?
|
| Signal Transduction | 19 | 2019 | 23419 | 0.180 |
Why?
|
| Necrosis | 2 | 2024 | 1610 | 0.180 |
Why?
|
| Analgesia | 2 | 2022 | 461 | 0.180 |
Why?
|
| Macular Degeneration | 2 | 2019 | 1009 | 0.180 |
Why?
|
| Spinal Cord | 2 | 2021 | 1807 | 0.180 |
Why?
|
| Wnt Proteins | 2 | 2018 | 720 | 0.170 |
Why?
|
| Vestibular Nerve | 2 | 2015 | 101 | 0.170 |
Why?
|
| Organophosphorus Compounds | 1 | 2021 | 207 | 0.170 |
Why?
|
| STAT3 Transcription Factor | 2 | 2016 | 872 | 0.170 |
Why?
|
| Neoplasms, Second Primary | 1 | 2008 | 1052 | 0.170 |
Why?
|
| Mutation | 21 | 2024 | 30004 | 0.170 |
Why?
|
| Spheroids, Cellular | 4 | 2017 | 329 | 0.170 |
Why?
|
| Burkitt Lymphoma | 1 | 2022 | 335 | 0.170 |
Why?
|
| Ice | 1 | 2020 | 102 | 0.170 |
Why?
|
| Cryotherapy | 1 | 2020 | 160 | 0.160 |
Why?
|
| Purpura, Thrombotic Thrombocytopenic | 1 | 2021 | 131 | 0.160 |
Why?
|
| Retinal Neurons | 1 | 2019 | 67 | 0.160 |
Why?
|
| Genes, Neurofibromatosis 1 | 4 | 2013 | 74 | 0.160 |
Why?
|
| Sequence Analysis, RNA | 3 | 2022 | 2011 | 0.160 |
Why?
|
| Magnetic Resonance Imaging | 21 | 2024 | 36415 | 0.160 |
Why?
|
| Carboxyhemoglobin | 1 | 2019 | 83 | 0.160 |
Why?
|
| Capsid | 1 | 2021 | 433 | 0.160 |
Why?
|
| Receptors, Eph Family | 1 | 2018 | 45 | 0.150 |
Why?
|
| Myelin Sheath | 3 | 2022 | 653 | 0.150 |
Why?
|
| Male | 56 | 2024 | 360703 | 0.150 |
Why?
|
| Gene Deletion | 6 | 2018 | 2658 | 0.150 |
Why?
|
| Connective Tissue Diseases | 1 | 2021 | 285 | 0.150 |
Why?
|
| Astrocytes | 4 | 2019 | 1341 | 0.150 |
Why?
|
| Retinal Cone Photoreceptor Cells | 1 | 2019 | 184 | 0.150 |
Why?
|
| Endometrium | 1 | 2001 | 403 | 0.150 |
Why?
|
| CARD Signaling Adaptor Proteins | 1 | 2019 | 159 | 0.150 |
Why?
|
| Pericytes | 1 | 2020 | 295 | 0.150 |
Why?
|
| beta Catenin | 2 | 2016 | 1042 | 0.150 |
Why?
|
| Mosaicism | 1 | 2021 | 477 | 0.150 |
Why?
|
| Gene Silencing | 3 | 2014 | 1495 | 0.140 |
Why?
|
| Retina | 2 | 2019 | 2656 | 0.140 |
Why?
|
| Loss of Heterozygosity | 7 | 2017 | 662 | 0.140 |
Why?
|
| Adult | 46 | 2024 | 221120 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-met | 2 | 2019 | 566 | 0.140 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p15 | 2 | 2018 | 70 | 0.140 |
Why?
|
| Glycoproteins | 1 | 2005 | 2203 | 0.140 |
Why?
|
| Cell Transformation, Neoplastic | 6 | 2018 | 2820 | 0.140 |
Why?
|
| Dystrophin | 1 | 2018 | 281 | 0.140 |
Why?
|
| Glutaminase | 1 | 2017 | 32 | 0.140 |
Why?
|
| Perivascular Epithelioid Cell Neoplasms | 1 | 2018 | 77 | 0.140 |
Why?
|
| Arachnoid | 4 | 2011 | 50 | 0.140 |
Why?
|
| Endopeptidases | 1 | 2020 | 766 | 0.140 |
Why?
|
| Epithelium | 2 | 2001 | 1603 | 0.140 |
Why?
|
| Lyme Disease | 1 | 2023 | 631 | 0.140 |
Why?
|
| Diabetic Retinopathy | 2 | 2017 | 1276 | 0.140 |
Why?
|
| Melanoma | 3 | 2022 | 5694 | 0.140 |
Why?
|
| Fibroma | 1 | 2018 | 190 | 0.130 |
Why?
|
| Immunoenzyme Techniques | 3 | 2013 | 1703 | 0.130 |
Why?
|
| Stromal Cells | 2 | 2020 | 1329 | 0.130 |
Why?
|
| Female | 56 | 2024 | 392552 | 0.130 |
Why?
|
| Insulator Elements | 1 | 2015 | 27 | 0.130 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2023 | 1838 | 0.130 |
Why?
|
| Mucorales | 1 | 2016 | 35 | 0.130 |
Why?
|
| Proteins | 9 | 2012 | 5993 | 0.130 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 2016 | 178 | 0.130 |
Why?
|
| Syncope | 1 | 2019 | 428 | 0.130 |
Why?
|
| Inclusion Bodies | 1 | 2017 | 279 | 0.130 |
Why?
|
| Alzheimer Disease | 1 | 2017 | 8606 | 0.130 |
Why?
|
| Germ-Line Mutation | 7 | 2020 | 1852 | 0.130 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2006 | 1462 | 0.120 |
Why?
|
| Neuroglia | 2 | 2019 | 953 | 0.120 |
Why?
|
| Biological Specimen Banks | 2 | 2021 | 780 | 0.120 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2013 | 1651 | 0.120 |
Why?
|
| Nerve Tissue Proteins | 3 | 2017 | 4404 | 0.120 |
Why?
|
| Child | 17 | 2024 | 80154 | 0.120 |
Why?
|
| Central Nervous System Diseases | 1 | 2019 | 521 | 0.120 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2017 | 355 | 0.120 |
Why?
|
| Cerebrospinal Fluid Shunts | 1 | 2016 | 195 | 0.120 |
Why?
|
| Disease Progression | 11 | 2018 | 13511 | 0.120 |
Why?
|
| Hemangioblastoma | 1 | 2014 | 62 | 0.120 |
Why?
|
| Macrophages | 4 | 2015 | 5755 | 0.120 |
Why?
|
| Phthalazines | 1 | 2017 | 383 | 0.120 |
Why?
|
| Integrases | 3 | 2013 | 518 | 0.120 |
Why?
|
| Neoplasm Recurrence, Local | 5 | 2015 | 9278 | 0.110 |
Why?
|
| Inflammasomes | 1 | 2019 | 526 | 0.110 |
Why?
|
| Telomerase | 2 | 2018 | 741 | 0.110 |
Why?
|
| Retinal Neovascularization | 1 | 2017 | 288 | 0.110 |
Why?
|
| DNA Mutational Analysis | 5 | 2008 | 4107 | 0.110 |
Why?
|
| Tumor Microenvironment | 5 | 2021 | 3875 | 0.110 |
Why?
|
| Ganglia, Spinal | 2 | 2014 | 525 | 0.110 |
Why?
|
| Middle Aged | 33 | 2024 | 220858 | 0.110 |
Why?
|
| Retinal Vessels | 1 | 2019 | 854 | 0.110 |
Why?
|
| Cyclooxygenase 2 | 1 | 2016 | 597 | 0.110 |
Why?
|
| Pyrimidines | 3 | 2021 | 3027 | 0.110 |
Why?
|
| Neoplastic Stem Cells | 3 | 2011 | 1348 | 0.110 |
Why?
|
| Automobile Driving | 1 | 2019 | 445 | 0.110 |
Why?
|
| Nerve Block | 1 | 2020 | 706 | 0.110 |
Why?
|
| Genes | 1 | 1997 | 1820 | 0.110 |
Why?
|
| Human papillomavirus 16 | 1 | 2015 | 267 | 0.110 |
Why?
|
| Quinolines | 2 | 2018 | 764 | 0.110 |
Why?
|
| Neuroendocrine Tumors | 2 | 2011 | 642 | 0.110 |
Why?
|
| Astrocytoma | 2 | 2010 | 774 | 0.110 |
Why?
|
| Repressor Proteins | 6 | 2015 | 2974 | 0.110 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2019 | 781 | 0.110 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2016 | 4567 | 0.100 |
Why?
|
| Turner Syndrome | 1 | 2014 | 129 | 0.100 |
Why?
|
| Osteosarcoma | 1 | 1998 | 896 | 0.100 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2022 | 1549 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 3 | 2 | 2014 | 322 | 0.100 |
Why?
|
| Gene Expression | 2 | 2019 | 7571 | 0.100 |
Why?
|
| Transduction, Genetic | 5 | 2021 | 900 | 0.100 |
Why?
|
| Receptors, Estrogen | 1 | 2001 | 2208 | 0.100 |
Why?
|
| Malformations of Cortical Development | 1 | 2014 | 176 | 0.100 |
Why?
|
| Demyelinating Diseases | 1 | 2015 | 352 | 0.100 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2018 | 696 | 0.100 |
Why?
|
| Immediate-Early Proteins | 1 | 2015 | 444 | 0.100 |
Why?
|
| Ocular Motility Disorders | 1 | 2013 | 144 | 0.100 |
Why?
|
| Sural Nerve | 1 | 2012 | 105 | 0.100 |
Why?
|
| Microglia | 3 | 2019 | 1358 | 0.100 |
Why?
|
| Promoter Regions, Genetic | 5 | 2019 | 5773 | 0.100 |
Why?
|
| Antigen Presentation | 1 | 2017 | 1251 | 0.100 |
Why?
|
| MicroRNAs | 3 | 2015 | 3758 | 0.100 |
Why?
|
| src-Family Kinases | 1 | 2014 | 536 | 0.100 |
Why?
|
| Antibodies, Monoclonal | 3 | 2017 | 9187 | 0.100 |
Why?
|
| Angiostatins | 1 | 2011 | 64 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 11 | 2019 | 22128 | 0.100 |
Why?
|
| Molecular Targeted Therapy | 3 | 2019 | 2813 | 0.100 |
Why?
|
| Orbital Diseases | 1 | 2013 | 178 | 0.100 |
Why?
|
| Meningitis | 1 | 2013 | 217 | 0.100 |
Why?
|
| Antineoplastic Agents | 5 | 2018 | 13632 | 0.100 |
Why?
|
| p21-Activated Kinases | 2 | 2010 | 127 | 0.100 |
Why?
|
| Neurosurgical Procedures | 4 | 2017 | 2067 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 1 | 3 | 2009 | 638 | 0.090 |
Why?
|
| Edema | 2 | 2015 | 764 | 0.090 |
Why?
|
| Myelin Proteolipid Protein | 1 | 2011 | 107 | 0.090 |
Why?
|
| Consciousness Disorders | 1 | 2016 | 441 | 0.090 |
Why?
|
| Gene Transfer Techniques | 3 | 2021 | 1201 | 0.090 |
Why?
|
| Luciferases, Firefly | 1 | 2010 | 37 | 0.090 |
Why?
|
| Fluorescein | 1 | 2011 | 175 | 0.090 |
Why?
|
| Pain | 3 | 2022 | 5072 | 0.090 |
Why?
|
| Ophthalmoscopy | 1 | 2011 | 171 | 0.090 |
Why?
|
| Antifungal Agents | 1 | 2016 | 752 | 0.090 |
Why?
|
| Retinal Artery | 1 | 2011 | 109 | 0.090 |
Why?
|
| Cell Division | 5 | 2008 | 4451 | 0.090 |
Why?
|
| Muscle, Skeletal | 2 | 2019 | 4947 | 0.090 |
Why?
|
| Genes, Tumor Suppressor | 4 | 2009 | 1057 | 0.090 |
Why?
|
| Intramolecular Oxidoreductases | 1 | 2011 | 105 | 0.090 |
Why?
|
| Paraproteinemias | 1 | 2013 | 250 | 0.090 |
Why?
|
| ras Proteins | 2 | 2013 | 1055 | 0.090 |
Why?
|
| Skull Base Neoplasms | 2 | 2017 | 270 | 0.090 |
Why?
|
| Nitric Oxide Synthase | 1 | 2013 | 909 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-akt | 4 | 2013 | 2455 | 0.090 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2015 | 610 | 0.090 |
Why?
|
| RNA, Small Interfering | 5 | 2016 | 3412 | 0.090 |
Why?
|
| Prognosis | 13 | 2019 | 29688 | 0.090 |
Why?
|
| Muscle Weakness | 3 | 2012 | 412 | 0.090 |
Why?
|
| Aged | 20 | 2024 | 169292 | 0.090 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2016 | 1132 | 0.090 |
Why?
|
| Lipocalins | 1 | 2011 | 161 | 0.090 |
Why?
|
| Oncogenes | 1 | 2015 | 1220 | 0.090 |
Why?
|
| Central Nervous System | 1 | 1997 | 1333 | 0.080 |
Why?
|
| Radiography | 3 | 2011 | 6974 | 0.080 |
Why?
|
| Marfan Syndrome | 1 | 2012 | 236 | 0.080 |
Why?
|
| Cerebellar Neoplasms | 1 | 2014 | 586 | 0.080 |
Why?
|
| Rhabdoid Tumor | 1 | 2012 | 210 | 0.080 |
Why?
|
| Apoptosis | 4 | 2019 | 9478 | 0.080 |
Why?
|
| Neovascularization, Pathologic | 2 | 2017 | 2636 | 0.080 |
Why?
|
| Nitriles | 1 | 2014 | 971 | 0.080 |
Why?
|
| Epigenesis, Genetic | 2 | 2020 | 3788 | 0.080 |
Why?
|
| Prosencephalon | 1 | 2011 | 305 | 0.080 |
Why?
|
| Mice, SCID | 4 | 2018 | 2621 | 0.080 |
Why?
|
| Cell Cycle Proteins | 4 | 2018 | 3446 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 7 | 2015 | 6067 | 0.080 |
Why?
|
| Down-Regulation | 3 | 2015 | 2916 | 0.080 |
Why?
|
| Aniline Compounds | 1 | 2014 | 1073 | 0.080 |
Why?
|
| Confusion | 1 | 2011 | 278 | 0.080 |
Why?
|
| Blotting, Western | 4 | 2008 | 5032 | 0.080 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2018 | 1158 | 0.080 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2023 | 4574 | 0.080 |
Why?
|
| Adolescent | 20 | 2022 | 88300 | 0.080 |
Why?
|
| Glial Fibrillary Acidic Protein | 2 | 2015 | 550 | 0.080 |
Why?
|
| Genomics | 3 | 2020 | 5829 | 0.080 |
Why?
|
| Cyclic AMP-Dependent Protein Kinase RIalpha Subunit | 1 | 2008 | 24 | 0.080 |
Why?
|
| JC Virus | 1 | 2009 | 87 | 0.080 |
Why?
|
| Teratoma | 1 | 2012 | 404 | 0.080 |
Why?
|
| Osteoblastoma | 1 | 2008 | 24 | 0.080 |
Why?
|
| Consensus | 4 | 2022 | 3134 | 0.080 |
Why?
|
| Evoked Potentials, Motor | 1 | 2012 | 464 | 0.080 |
Why?
|
| Matrix Metalloproteinase 14 | 1 | 2008 | 60 | 0.080 |
Why?
|
| SOX9 Transcription Factor | 1 | 2009 | 145 | 0.080 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2019 | 1318 | 0.080 |
Why?
|
| Cysts | 1 | 2013 | 680 | 0.080 |
Why?
|
| Tight Junctions | 1 | 2011 | 324 | 0.080 |
Why?
|
| Gene Fusion | 2 | 2022 | 355 | 0.080 |
Why?
|
| Tomography, X-Ray Computed | 7 | 2018 | 20588 | 0.080 |
Why?
|
| Cell Adhesion Molecules | 1 | 2014 | 1603 | 0.080 |
Why?
|
| DNA, Viral | 1 | 2015 | 2195 | 0.080 |
Why?
|
| Earache | 1 | 2007 | 14 | 0.080 |
Why?
|
| Leukoencephalopathy, Progressive Multifocal | 1 | 2009 | 133 | 0.080 |
Why?
|
| Intermediate Filaments | 1 | 2008 | 171 | 0.070 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2021 | 5665 | 0.070 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2011 | 3596 | 0.070 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2017 | 5301 | 0.070 |
Why?
|
| Prolactinoma | 1 | 2008 | 113 | 0.070 |
Why?
|
| Luminescent Proteins | 1 | 2010 | 834 | 0.070 |
Why?
|
| Peroxidase | 1 | 2011 | 610 | 0.070 |
Why?
|
| Genetic Testing | 4 | 2021 | 3537 | 0.070 |
Why?
|
| Young Adult | 13 | 2022 | 59222 | 0.070 |
Why?
|
| Gene Expression Profiling | 6 | 2019 | 9417 | 0.070 |
Why?
|
| Pigmentation | 1 | 2008 | 143 | 0.070 |
Why?
|
| Central Nervous System Cysts | 1 | 2007 | 56 | 0.070 |
Why?
|
| Pneumocephalus | 1 | 2007 | 47 | 0.070 |
Why?
|
| Glaucoma | 1 | 2017 | 1186 | 0.070 |
Why?
|
| Vasculitis | 1 | 2011 | 522 | 0.070 |
Why?
|
| Cell Lineage | 2 | 2019 | 2549 | 0.070 |
Why?
|
| Liver | 2 | 2013 | 7512 | 0.070 |
Why?
|
| Transgenes | 3 | 2021 | 1008 | 0.070 |
Why?
|
| Genetic Association Studies | 1 | 2016 | 2731 | 0.070 |
Why?
|
| Polyomavirus Infections | 1 | 2009 | 192 | 0.070 |
Why?
|
| Microscopy, Confocal | 1 | 2013 | 1967 | 0.070 |
Why?
|
| Anterior Horn Cells | 1 | 2006 | 17 | 0.070 |
Why?
|
| Green Fluorescent Proteins | 4 | 2018 | 2062 | 0.070 |
Why?
|
| Cord Blood Stem Cell Transplantation | 1 | 2009 | 305 | 0.070 |
Why?
|
| Mice, Transgenic | 6 | 2016 | 9520 | 0.070 |
Why?
|
| Speech Disorders | 1 | 2007 | 180 | 0.070 |
Why?
|
| Tamoxifen | 1 | 2011 | 965 | 0.070 |
Why?
|
| Mice, Knockout | 8 | 2017 | 14392 | 0.070 |
Why?
|
| Cells, Cultured | 8 | 2016 | 18927 | 0.070 |
Why?
|
| Piperazines | 1 | 2017 | 2522 | 0.070 |
Why?
|
| Bone Neoplasms | 1 | 1998 | 2527 | 0.070 |
Why?
|
| Neoplasm Transplantation | 3 | 2018 | 2010 | 0.070 |
Why?
|
| Tumor Virus Infections | 1 | 2009 | 435 | 0.070 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2008 | 459 | 0.070 |
Why?
|
| RNA | 2 | 2022 | 2709 | 0.070 |
Why?
|
| Spinal Nerve Roots | 1 | 2006 | 121 | 0.070 |
Why?
|
| Headache | 2 | 2011 | 1255 | 0.060 |
Why?
|
| Herpesvirus 1, Human | 1 | 2011 | 739 | 0.060 |
Why?
|
| Research | 1 | 2014 | 1976 | 0.060 |
Why?
|
| Motor Neuron Disease | 1 | 2006 | 97 | 0.060 |
Why?
|
| Skull Base | 1 | 2008 | 292 | 0.060 |
Why?
|
| Exons | 4 | 2014 | 2380 | 0.060 |
Why?
|
| Endothelial Cells | 2 | 2017 | 3552 | 0.060 |
Why?
|
| Electromyography | 2 | 2012 | 1393 | 0.060 |
Why?
|
| Unconsciousness | 1 | 2007 | 249 | 0.060 |
Why?
|
| Gyrus Cinguli | 1 | 2012 | 1114 | 0.060 |
Why?
|
| Cluster Analysis | 2 | 2015 | 2706 | 0.060 |
Why?
|
| Genetic Markers | 3 | 2008 | 2599 | 0.060 |
Why?
|
| Monitoring, Intraoperative | 1 | 2012 | 944 | 0.060 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2007 | 219 | 0.060 |
Why?
|
| Intracranial Hypertension | 1 | 2007 | 193 | 0.060 |
Why?
|
| Neoplasm Invasiveness | 5 | 2017 | 3590 | 0.060 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2013 | 1249 | 0.060 |
Why?
|
| Calcinosis | 2 | 2011 | 1477 | 0.060 |
Why?
|
| Immunophenotyping | 2 | 2022 | 1867 | 0.060 |
Why?
|
| Neurogenesis | 1 | 2011 | 862 | 0.060 |
Why?
|
| Cadherins | 1 | 2009 | 902 | 0.060 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2008 | 592 | 0.060 |
Why?
|
| Mice, Inbred NOD | 2 | 2019 | 1822 | 0.060 |
Why?
|
| Collagen Type I | 1 | 2008 | 616 | 0.060 |
Why?
|
| Radiotherapy | 2 | 2018 | 1500 | 0.060 |
Why?
|
| Mice, 129 Strain | 2 | 2016 | 370 | 0.060 |
Why?
|
| Ki-67 Antigen | 2 | 2017 | 628 | 0.060 |
Why?
|
| Memory Disorders | 1 | 2011 | 1198 | 0.060 |
Why?
|
| DNA Repair Enzymes | 2 | 2012 | 346 | 0.060 |
Why?
|
| DNA Methylation | 5 | 2020 | 4384 | 0.060 |
Why?
|
| Orbital Myositis | 1 | 2024 | 25 | 0.060 |
Why?
|
| Genetic Heterogeneity | 2 | 2019 | 734 | 0.060 |
Why?
|
| Liver Diseases | 1 | 2012 | 1301 | 0.060 |
Why?
|
| Morpholines | 2 | 2018 | 581 | 0.060 |
Why?
|
| Treatment Outcome | 9 | 2021 | 64681 | 0.050 |
Why?
|
| Phenotype | 7 | 2016 | 16575 | 0.050 |
Why?
|
| Injections | 2 | 2020 | 832 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2009 | 3777 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 7 | 2020 | 17897 | 0.050 |
Why?
|
| Genotype | 4 | 2012 | 12985 | 0.050 |
Why?
|
| Radiation Injuries | 1 | 2010 | 1191 | 0.050 |
Why?
|
| Hedgehog Proteins | 1 | 2008 | 769 | 0.050 |
Why?
|
| Lectins | 1 | 2005 | 489 | 0.050 |
Why?
|
| Immunotherapy | 1 | 2018 | 4642 | 0.050 |
Why?
|
| Adipokines | 1 | 2005 | 307 | 0.050 |
Why?
|
| Epilepsy | 3 | 2015 | 3304 | 0.050 |
Why?
|
| Hospitals, Pediatric | 1 | 2012 | 1862 | 0.050 |
Why?
|
| Proteomics | 2 | 2021 | 3840 | 0.050 |
Why?
|
| RNA, Messenger | 5 | 2018 | 12747 | 0.050 |
Why?
|
| Blood Proteins | 2 | 1997 | 1173 | 0.050 |
Why?
|
| Aged, 80 and over | 6 | 2018 | 58952 | 0.050 |
Why?
|
| Pediatrics | 1 | 2017 | 3590 | 0.050 |
Why?
|
| Embryonic Stem Cells | 1 | 2009 | 1246 | 0.050 |
Why?
|
| Kidney Neoplasms | 2 | 2017 | 4251 | 0.050 |
Why?
|
| Electroencephalography | 2 | 2014 | 6242 | 0.050 |
Why?
|
| Rats | 5 | 2022 | 23705 | 0.050 |
Why?
|
| Seizures | 1 | 2014 | 2965 | 0.050 |
Why?
|
| Cafe-au-Lait Spots | 1 | 2021 | 19 | 0.050 |
Why?
|
| Sarcoma | 2 | 2013 | 1800 | 0.050 |
Why?
|
| Epithelial Cells | 1 | 2013 | 3671 | 0.050 |
Why?
|
| Genes, p53 | 2 | 2009 | 713 | 0.050 |
Why?
|
| Comparative Genomic Hybridization | 2 | 2015 | 473 | 0.050 |
Why?
|
| Spinal Diseases | 1 | 2006 | 562 | 0.050 |
Why?
|
| Chordoma | 1 | 2004 | 347 | 0.050 |
Why?
|
| Fluorescent Antibody Technique | 3 | 2010 | 2468 | 0.050 |
Why?
|
| Blood Vessels | 2 | 2019 | 1111 | 0.050 |
Why?
|
| Sciatic Neuropathy | 1 | 2021 | 76 | 0.050 |
Why?
|
| Base Sequence | 4 | 2015 | 12404 | 0.050 |
Why?
|
| Synovial Fluid | 1 | 2023 | 393 | 0.050 |
Why?
|
| Nerve Regeneration | 2 | 2017 | 796 | 0.050 |
Why?
|
| Child, Preschool | 8 | 2018 | 42225 | 0.040 |
Why?
|
| Transplantation, Heterologous | 4 | 2011 | 2381 | 0.040 |
Why?
|
| Autoantigens | 1 | 2005 | 888 | 0.040 |
Why?
|
| Bone and Bones | 1 | 2011 | 2568 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2019 | 3634 | 0.040 |
Why?
|
| Protein-Tyrosine Kinases | 3 | 2021 | 2426 | 0.040 |
Why?
|
| Mice, Mutant Strains | 3 | 2013 | 1751 | 0.040 |
Why?
|
| Radiotherapy, Adjuvant | 2 | 2015 | 1784 | 0.040 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2009 | 1878 | 0.040 |
Why?
|
| Retinal Horizontal Cells | 1 | 2019 | 10 | 0.040 |
Why?
|
| Retrospective Studies | 11 | 2021 | 80675 | 0.040 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2020 | 183 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2001 | 350 | 0.040 |
Why?
|
| Rodentia | 1 | 2021 | 261 | 0.040 |
Why?
|
| Amacrine Cells | 1 | 2019 | 52 | 0.040 |
Why?
|
| Nuclear Proteins | 2 | 2016 | 5783 | 0.040 |
Why?
|
| Retinal Bipolar Cells | 1 | 2019 | 46 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2018 | 15920 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2020 | 1240 | 0.040 |
Why?
|
| Losartan | 1 | 2021 | 263 | 0.040 |
Why?
|
| Alleles | 3 | 2023 | 6857 | 0.040 |
Why?
|
| Inflammation | 2 | 2011 | 10759 | 0.040 |
Why?
|
| Macaca fascicularis | 1 | 2021 | 901 | 0.040 |
Why?
|
| World Health Organization | 2 | 2015 | 1321 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2023 | 800 | 0.040 |
Why?
|
| Immunoblotting | 2 | 2015 | 1644 | 0.040 |
Why?
|
| Flow Cytometry | 3 | 2017 | 5871 | 0.040 |
Why?
|
| Cyclin D1 | 2 | 2012 | 451 | 0.040 |
Why?
|
| Up-Regulation | 3 | 2015 | 4111 | 0.040 |
Why?
|
| Sex Chromatin | 1 | 2018 | 19 | 0.040 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2020 | 303 | 0.040 |
Why?
|
| Disease-Free Survival | 3 | 2015 | 6819 | 0.040 |
Why?
|
| Osteoarthritis | 1 | 2006 | 1063 | 0.040 |
Why?
|
| Rats, Inbred F344 | 2 | 2011 | 826 | 0.040 |
Why?
|
| T Cell Transcription Factor 1 | 1 | 2018 | 72 | 0.040 |
Why?
|
| Autocrine Communication | 1 | 2019 | 169 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2008 | 2915 | 0.040 |
Why?
|
| Single-Cell Analysis | 2 | 2019 | 2452 | 0.040 |
Why?
|
| Retinal Rod Photoreceptor Cells | 1 | 2019 | 204 | 0.040 |
Why?
|
| Multiple Sclerosis | 1 | 2013 | 3222 | 0.040 |
Why?
|
| Protein Isoforms | 2 | 2013 | 1695 | 0.040 |
Why?
|
| Liver Neoplasms | 1 | 2013 | 4310 | 0.040 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2019 | 270 | 0.040 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 1999 | 219 | 0.040 |
Why?
|
| Axons | 2 | 2020 | 1671 | 0.040 |
Why?
|
| Mitotic Index | 1 | 2017 | 162 | 0.040 |
Why?
|
| Cell Survival | 2 | 2018 | 5778 | 0.040 |
Why?
|
| Combined Modality Therapy | 3 | 2017 | 8519 | 0.030 |
Why?
|
| Cohort Studies | 5 | 2020 | 41496 | 0.030 |
Why?
|
| Ligases | 1 | 1998 | 333 | 0.030 |
Why?
|
| beta 2-Microglobulin | 1 | 2017 | 329 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2001 | 2263 | 0.030 |
Why?
|
| Time-Lapse Imaging | 1 | 2017 | 194 | 0.030 |
Why?
|
| Phosphorylation | 3 | 2016 | 8300 | 0.030 |
Why?
|
| Quality of Life | 1 | 2018 | 13367 | 0.030 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2006 | 1228 | 0.030 |
Why?
|
| Cerebral Cortex | 2 | 2010 | 5775 | 0.030 |
Why?
|
| Pyridazines | 1 | 2018 | 202 | 0.030 |
Why?
|
| Brain Mapping | 1 | 2012 | 6635 | 0.030 |
Why?
|
| Predictive Value of Tests | 3 | 2018 | 15308 | 0.030 |
Why?
|
| Gliosis | 1 | 1997 | 245 | 0.030 |
Why?
|
| Genome, Human | 1 | 2009 | 4423 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2009 | 4190 | 0.030 |
Why?
|
| Rotarod Performance Test | 1 | 2015 | 63 | 0.030 |
Why?
|
| Apyrase | 1 | 2018 | 373 | 0.030 |
Why?
|
| Peripheral Nerves | 2 | 2011 | 479 | 0.030 |
Why?
|
| Glutamates | 1 | 2017 | 385 | 0.030 |
Why?
|
| Biopsy | 2 | 2018 | 6781 | 0.030 |
Why?
|
| Antigens, CD | 2 | 2018 | 4009 | 0.030 |
Why?
|
| Organ Culture Techniques | 1 | 2018 | 792 | 0.030 |
Why?
|
| DNA | 1 | 2009 | 7189 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2012 | 2058 | 0.030 |
Why?
|
| Diagnostic Imaging | 1 | 2009 | 3534 | 0.030 |
Why?
|
| Molecular Sequence Data | 4 | 2011 | 17598 | 0.030 |
Why?
|
| Cell Line | 3 | 2009 | 15545 | 0.030 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2017 | 426 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 2017 | 656 | 0.030 |
Why?
|
| Virus Replication | 2 | 2016 | 2426 | 0.030 |
Why?
|
| Epiretinal Membrane | 1 | 2015 | 73 | 0.030 |
Why?
|
| Angiopoietin-1 | 1 | 2015 | 122 | 0.030 |
Why?
|
| Adenosine Triphosphatases | 1 | 1999 | 833 | 0.030 |
Why?
|
| Frozen Sections | 1 | 2015 | 153 | 0.030 |
Why?
|
| Fibronectins | 1 | 1998 | 724 | 0.030 |
Why?
|
| Systems Biology | 1 | 2018 | 481 | 0.030 |
Why?
|
| Actins | 2 | 2015 | 2046 | 0.030 |
Why?
|
| Intraoperative Period | 1 | 2015 | 510 | 0.030 |
Why?
|
| Tissue Fixation | 1 | 2015 | 241 | 0.030 |
Why?
|
| Multiprotein Complexes | 2 | 2012 | 1112 | 0.030 |
Why?
|
| Autoantibodies | 1 | 2023 | 2119 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2024 | 22174 | 0.030 |
Why?
|
| Glutarates | 1 | 2015 | 243 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2014 | 2509 | 0.030 |
Why?
|
| Glutamine | 1 | 2017 | 574 | 0.030 |
Why?
|
| Pancreatic Neoplasms | 1 | 2011 | 5366 | 0.030 |
Why?
|
| HEK293 Cells | 2 | 2013 | 4243 | 0.030 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2015 | 267 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 18 | 2 | 2005 | 247 | 0.030 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2015 | 880 | 0.030 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2015 | 368 | 0.030 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2021 | 1625 | 0.030 |
Why?
|
| Retinal Ganglion Cells | 1 | 2019 | 810 | 0.030 |
Why?
|
| Acridine Orange | 1 | 2013 | 28 | 0.030 |
Why?
|
| Sirolimus | 2 | 2012 | 1540 | 0.030 |
Why?
|
| Infant | 5 | 2019 | 36170 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2001 | 20982 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 22 | 2 | 2005 | 346 | 0.030 |
Why?
|
| Radiation Tolerance | 1 | 2015 | 478 | 0.030 |
Why?
|
| Mutagenesis, Insertional | 1 | 2016 | 657 | 0.030 |
Why?
|
| Swine | 1 | 2023 | 5909 | 0.030 |
Why?
|
| Exotropia | 1 | 2013 | 64 | 0.030 |
Why?
|
| Injections, Intralesional | 1 | 2014 | 280 | 0.030 |
Why?
|
| Oxygen | 2 | 2017 | 4228 | 0.030 |
Why?
|
| Walking | 1 | 2020 | 1194 | 0.030 |
Why?
|
| Embryo, Mammalian | 3 | 2008 | 1668 | 0.030 |
Why?
|
| Muscular Atrophy | 1 | 2015 | 334 | 0.030 |
Why?
|
| Mediastinal Emphysema | 1 | 2012 | 29 | 0.030 |
Why?
|
| Neoplasms, Experimental | 1 | 2017 | 1225 | 0.030 |
Why?
|
| Point Mutation | 1 | 2017 | 1593 | 0.030 |
Why?
|
| Oncogene Protein v-akt | 1 | 2012 | 129 | 0.020 |
Why?
|
| Transfection | 2 | 2010 | 5748 | 0.020 |
Why?
|
| Mitosis | 1 | 2017 | 1187 | 0.020 |
Why?
|
| Curcumin | 1 | 2013 | 98 | 0.020 |
Why?
|
| Lymphoma, B-Cell, Marginal Zone | 1 | 2013 | 178 | 0.020 |
Why?
|
| Libido | 1 | 2012 | 124 | 0.020 |
Why?
|
| Time Factors | 5 | 2015 | 39957 | 0.020 |
Why?
|
| British Columbia | 1 | 2012 | 241 | 0.020 |
Why?
|
| Transaminases | 1 | 2012 | 199 | 0.020 |
Why?
|
| Nucleoside-Phosphate Kinase | 1 | 2011 | 24 | 0.020 |
Why?
|
| Blood-Brain Barrier | 1 | 2018 | 1028 | 0.020 |
Why?
|
| Hypertrophy | 1 | 2013 | 558 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2014 | 6486 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2015 | 1900 | 0.020 |
Why?
|
| Claudins | 1 | 2012 | 117 | 0.020 |
Why?
|
| DNA Modification Methylases | 1 | 2012 | 210 | 0.020 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2017 | 799 | 0.020 |
Why?
|
| Indocyanine Green | 1 | 2013 | 234 | 0.020 |
Why?
|
| CpG Islands | 1 | 2015 | 1190 | 0.020 |
Why?
|
| Chromosome Deletion | 2 | 2009 | 1386 | 0.020 |
Why?
|
| Naphthyridines | 1 | 2012 | 143 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2017 | 2643 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2013 | 924 | 0.020 |
Why?
|
| Paired Box Transcription Factors | 1 | 2011 | 206 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 1602 | 0.020 |
Why?
|
| Vero Cells | 1 | 2011 | 482 | 0.020 |
Why?
|
| DNA Helicases | 1 | 2016 | 850 | 0.020 |
Why?
|
| Intermediate Filament Proteins | 1 | 2011 | 262 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 1998 | 1720 | 0.020 |
Why?
|
| RNA Stability | 1 | 2012 | 317 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2023 | 4373 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2019 | 2475 | 0.020 |
Why?
|
| 3' Untranslated Regions | 1 | 2012 | 514 | 0.020 |
Why?
|
| Metaplasia | 1 | 2011 | 324 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2005 | 11119 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2015 | 987 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2017 | 1662 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2010 | 382 | 0.020 |
Why?
|
| Pyramidal Tracts | 1 | 2012 | 251 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2020 | 3549 | 0.020 |
Why?
|
| Terminology as Topic | 1 | 2017 | 1528 | 0.020 |
Why?
|
| Cell Differentiation | 3 | 2018 | 11512 | 0.020 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2011 | 242 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2018 | 6200 | 0.020 |
Why?
|
| Models, Biological | 2 | 2008 | 9458 | 0.020 |
Why?
|
| Cell Separation | 1 | 2015 | 1721 | 0.020 |
Why?
|
| Benzamides | 1 | 2015 | 1371 | 0.020 |
Why?
|
| Janus Kinase 2 | 1 | 2013 | 559 | 0.020 |
Why?
|
| Congresses as Topic | 1 | 2014 | 803 | 0.020 |
Why?
|
| Neuropilin-2 | 1 | 2009 | 55 | 0.020 |
Why?
|
| Luminescence | 1 | 2009 | 108 | 0.020 |
Why?
|
| Clone Cells | 2 | 2004 | 1668 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2020 | 8164 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2024 | 14675 | 0.020 |
Why?
|
| Neuropilin-1 | 1 | 2009 | 90 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2012 | 1989 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2015 | 1360 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2017 | 2138 | 0.020 |
Why?
|
| Risk Assessment | 3 | 2017 | 24022 | 0.020 |
Why?
|
| Papillomaviridae | 1 | 2015 | 1120 | 0.020 |
Why?
|
| Endpoint Determination | 1 | 2011 | 590 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 1998 | 1892 | 0.020 |
Why?
|
| Neural Stem Cells | 1 | 2016 | 886 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 2012 | 2561 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2011 | 748 | 0.020 |
Why?
|
| Sulfonamides | 1 | 2018 | 1977 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2017 | 2881 | 0.020 |
Why?
|
| Receptor, Nerve Growth Factor | 1 | 2008 | 48 | 0.020 |
Why?
|
| Embryo Loss | 1 | 2008 | 55 | 0.020 |
Why?
|
| DNA Damage | 1 | 2018 | 2443 | 0.020 |
Why?
|
| GTPase-Activating Proteins | 1 | 2011 | 470 | 0.020 |
Why?
|
| Viral Proteins | 1 | 2015 | 1798 | 0.020 |
Why?
|
| Standard of Care | 1 | 2011 | 550 | 0.020 |
Why?
|
| RNA Splicing | 1 | 2012 | 896 | 0.020 |
Why?
|
| Catenins | 1 | 2007 | 44 | 0.020 |
Why?
|
| Eye Proteins | 1 | 2011 | 632 | 0.020 |
Why?
|
| 3T3 Cells | 1 | 2009 | 1083 | 0.020 |
Why?
|
| Plasmids | 1 | 2013 | 2261 | 0.020 |
Why?
|
| Weights and Measures | 1 | 2007 | 41 | 0.020 |
Why?
|
| Follow-Up Studies | 3 | 2015 | 39127 | 0.020 |
Why?
|
| Survival Analysis | 2 | 2016 | 10088 | 0.020 |
Why?
|
| Antibodies | 1 | 2015 | 2415 | 0.020 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2008 | 199 | 0.020 |
Why?
|
| Protein Binding | 2 | 2015 | 9297 | 0.020 |
Why?
|
| Bromodeoxyuridine | 1 | 2007 | 310 | 0.020 |
Why?
|
| Clinical Trials as Topic | 2 | 2014 | 8002 | 0.020 |
Why?
|
| Histological Techniques | 1 | 2007 | 193 | 0.020 |
Why?
|
| Fluorescence | 1 | 2009 | 751 | 0.020 |
Why?
|
| Binding Sites | 1 | 2015 | 5988 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2012 | 2665 | 0.020 |
Why?
|
| DNA Primers | 1 | 2011 | 2814 | 0.020 |
Why?
|
| Proline | 1 | 2008 | 455 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2013 | 1892 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2008 | 667 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2017 | 4909 | 0.020 |
Why?
|
| Nervous System Diseases | 1 | 2017 | 1663 | 0.020 |
Why?
|
| Blood Chemical Analysis | 1 | 2008 | 436 | 0.020 |
Why?
|
| Gels | 1 | 2008 | 420 | 0.020 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2020 | 3092 | 0.020 |
Why?
|
| Prolactin | 1 | 2008 | 625 | 0.020 |
Why?
|
| Genes, ras | 1 | 2009 | 654 | 0.020 |
Why?
|
| Neoplasms | 1 | 2015 | 22142 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2009 | 546 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2013 | 3778 | 0.020 |
Why?
|
| Stem Cells | 2 | 2011 | 3517 | 0.020 |
Why?
|
| Proportional Hazards Models | 2 | 2014 | 12474 | 0.020 |
Why?
|
| Herpes Simplex | 1 | 2009 | 465 | 0.020 |
Why?
|
| Cerebrospinal Fluid | 1 | 2009 | 544 | 0.020 |
Why?
|
| Population Surveillance | 1 | 2016 | 2598 | 0.020 |
Why?
|
| Chromosome Aberrations | 1 | 2012 | 1767 | 0.020 |
Why?
|
| Fibroblasts | 2 | 2009 | 4138 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2010 | 4052 | 0.020 |
Why?
|
| Malnutrition | 1 | 2012 | 622 | 0.020 |
Why?
|
| Face | 1 | 2012 | 1025 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 2854 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2013 | 8998 | 0.020 |
Why?
|
| Histones | 1 | 2016 | 2570 | 0.020 |
Why?
|
| Microdissection | 1 | 2005 | 151 | 0.020 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2009 | 677 | 0.020 |
Why?
|
| Glucose | 1 | 2017 | 4342 | 0.020 |
Why?
|
| Fatigue | 1 | 2012 | 1550 | 0.020 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2007 | 714 | 0.020 |
Why?
|
| Cell Movement | 1 | 2017 | 5195 | 0.020 |
Why?
|
| Arginine | 1 | 2008 | 920 | 0.010 |
Why?
|
| Recurrence | 1 | 2017 | 8457 | 0.010 |
Why?
|
| Sacrococcygeal Region | 1 | 2004 | 53 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 2009 | 1202 | 0.010 |
Why?
|
| Gadolinium DTPA | 1 | 2008 | 823 | 0.010 |
Why?
|
| Psychomotor Performance | 1 | 2013 | 1880 | 0.010 |
Why?
|
| Nitric Oxide | 1 | 2013 | 2137 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2023 | 7407 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2007 | 1762 | 0.010 |
Why?
|
| Survival Rate | 2 | 2013 | 12728 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 3803 | 0.010 |
Why?
|
| Likelihood Functions | 1 | 2007 | 991 | 0.010 |
Why?
|
| Biometry | 1 | 2007 | 563 | 0.010 |
Why?
|
| MAP Kinase Signaling System | 1 | 2011 | 1480 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2015 | 3461 | 0.010 |
Why?
|
| Chromatin | 1 | 2015 | 2946 | 0.010 |
Why?
|
| MAP Kinase Kinase 2 | 1 | 2004 | 92 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2008 | 1168 | 0.010 |
Why?
|
| Research Design | 2 | 2011 | 6180 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2014 | 4739 | 0.010 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2004 | 203 | 0.010 |
Why?
|
| Thymidine Kinase | 1 | 2004 | 286 | 0.010 |
Why?
|
| Kinetics | 1 | 2011 | 6312 | 0.010 |
Why?
|
| Ganciclovir | 1 | 2004 | 253 | 0.010 |
Why?
|
| RNA Interference | 1 | 2012 | 2816 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2013 | 6345 | 0.010 |
Why?
|
| Microsatellite Repeats | 1 | 2005 | 782 | 0.010 |
Why?
|
| Mutation, Missense | 1 | 2012 | 2567 | 0.010 |
Why?
|
| Papillomavirus Infections | 1 | 2015 | 1616 | 0.010 |
Why?
|
| Genetic Loci | 1 | 2012 | 2623 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 2008 | 1518 | 0.010 |
Why?
|
| Anorexia Nervosa | 1 | 2012 | 1361 | 0.010 |
Why?
|
| Paresis | 1 | 2004 | 176 | 0.010 |
Why?
|
| DNA Restriction Enzymes | 1 | 2003 | 548 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2008 | 2928 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2010 | 4851 | 0.010 |
Why?
|
| Longitudinal Studies | 2 | 2010 | 14610 | 0.010 |
Why?
|
| Cytokines | 1 | 2017 | 7386 | 0.010 |
Why?
|
| Cytoskeleton | 1 | 2007 | 1169 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2004 | 471 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2017 | 3417 | 0.010 |
Why?
|
| Transplantation Conditioning | 1 | 2009 | 1591 | 0.010 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2004 | 332 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2004 | 475 | 0.010 |
Why?
|
| Radiosurgery | 1 | 2011 | 1339 | 0.010 |
Why?
|
| Homeodomain Proteins | 1 | 2011 | 2414 | 0.010 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2017 | 3163 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2008 | 1404 | 0.010 |
Why?
|
| Phagocytosis | 1 | 2007 | 1525 | 0.010 |
Why?
|
| Reproducibility of Results | 2 | 2010 | 20118 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 11855 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2013 | 4537 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2004 | 636 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2016 | 7965 | 0.010 |
Why?
|
| Models, Structural | 1 | 2001 | 338 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2009 | 2926 | 0.010 |
Why?
|
| Weight Loss | 1 | 2012 | 2680 | 0.010 |
Why?
|
| Viscera | 1 | 2001 | 138 | 0.010 |
Why?
|
| Registries | 1 | 2016 | 8246 | 0.010 |
Why?
|
| Epilepsies, Partial | 1 | 2004 | 431 | 0.010 |
Why?
|
| Adaptation, Biological | 1 | 2001 | 147 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2015 | 6567 | 0.010 |
Why?
|
| Introns | 1 | 2003 | 968 | 0.010 |
Why?
|
| Receptors, Progesterone | 1 | 2005 | 1129 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2009 | 2864 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2004 | 13386 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2011 | 13402 | 0.010 |
Why?
|
| Genes, p16 | 1 | 1999 | 160 | 0.010 |
Why?
|
| Software | 1 | 2013 | 4431 | 0.010 |
Why?
|
| Massachusetts | 1 | 2011 | 8837 | 0.010 |
Why?
|
| Skin | 1 | 2012 | 4473 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2010 | 10756 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2008 | 4243 | 0.010 |
Why?
|
| Family Health | 1 | 2003 | 1254 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2004 | 3577 | 0.010 |
Why?
|
| Periodicity | 1 | 1999 | 347 | 0.010 |
Why?
|
| Spinal Neoplasms | 1 | 2004 | 703 | 0.010 |
Why?
|
| Risk Factors | 2 | 2015 | 74241 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 2001 | 1848 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 1998 | 864 | 0.010 |
Why?
|
| Protein Kinases | 1 | 2004 | 1607 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2021 | 54437 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2004 | 2091 | 0.010 |
Why?
|
| Graft vs Host Disease | 1 | 2009 | 3025 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2008 | 9652 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2015 | 12676 | 0.010 |
Why?
|
| Neurons | 1 | 2015 | 9429 | 0.010 |
Why?
|
| Contrast Media | 1 | 2008 | 5311 | 0.010 |
Why?
|
| Fetus | 1 | 2001 | 1864 | 0.010 |
Why?
|
| Incidence | 1 | 2011 | 21366 | 0.010 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2009 | 3610 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2000 | 3603 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2017 | 12159 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2010 | 15841 | 0.010 |
Why?
|
| Reference Values | 1 | 1999 | 4921 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2004 | 4513 | 0.010 |
Why?
|
| Antiviral Agents | 1 | 2004 | 3048 | 0.010 |
Why?
|
| Pregnancy | 2 | 2004 | 29893 | 0.010 |
Why?
|
| Infant, Newborn | 2 | 2000 | 26200 | 0.010 |
Why?
|
| Algorithms | 1 | 2010 | 14025 | 0.010 |
Why?
|
| Lung | 1 | 2005 | 9979 | 0.000 |
Why?
|
| Age Factors | 1 | 2001 | 18384 | 0.000 |
Why?
|